Precipio, Inc.
PRPO
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary andā¦ read more
Healthcare
Diagnostics & Research
8 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$23.96
Price+4.27%
$0.98
1Y
Price
Market Cap
$36.827m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+3.9%
EBITDA Margin-1.3%
Net Profit Margin-0.7%
Free Cash Flow Margin+3.9%
EBITDA Margin-1.3%
Net Profit Margin-0.7%
Free Cash Flow MarginRevenue
$21.525m
+34.8%
1y CAGR+33.8%
3y CAGR+26.9%
5y CAGREarnings
-$1.254m
+70.8%
1y CAGR+49.8%
3y CAGR+26.7%
5y CAGREPS
-$0.84
+71.3%
1y CAGR+54.8%
3y CAGR+33.0%
5y CAGRBook Value
$13.749m
$21.153m
Assets$7.404m
Liabilities$3.507m
DebtDebt to Assets
16.6%
9.7x
Debt to EBITDAFree Cash Flow
$589k
+172.7%
1y CAGR+110.8%
3y CAGR+80.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company